Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_assertion type Assertion NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_head.
- NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_provenance.
- NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_assertion evidence source_evidence_literature NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_provenance.
- NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_assertion SIO_000772 14607763 NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_provenance.
- NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_assertion wasDerivedFrom befree-2016 NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_provenance.
- NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_assertion wasGeneratedBy ECO_0000203 NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_provenance.